In the past, investigators have successfully used iron chelators to mitigate the cardiotoxicity of doxorubicin (DOX), a widely used anticancer drug that induces reactive oxygen species (ROS), oxidative damage, and apoptosis. Although intracellular iron plays a critical role in initiating DOX-induced apoptosis, the molecular mechanism(s) that link iron, ROS, and apoptosis are still unknown. In this study, we demonstrate that apoptosis results from the exposure of bovine aortic endothelial cells to DOX and that the apoptotic cell death is accompanied by a significant increase in cellular iron ( 55 Fe) uptake and activation of iron regulatory protein-1. Furthermore, DOX-induced iron uptake was shown to be mediated by the transferrin receptor (TfR)-dependent mechanism. Treatment with the anti-TfR antibody (IgA class) dramatically inhibited DOX-induced apoptosis, iron uptake, and intracellular oxidant formation as measured by fluorescence using dichlorodihydrofluorescein. Treatment with cell-permeable iron chelators and ROS scavengers inhibited DOX-induced cellular 55 Fe uptake, ROS formation, and apoptosis. Based on these findings, we conclude that DOX-induced iron signaling is regulated by the cell surface TfR expression, intracellular oxidant levels, and iron regulatory proteins. The implications of TfR-dependent iron transport in oxidant-induced apoptosis in endothelial cells are discussed.
Doxorubicin (DOX)
1 or adriamycin is a popular antitumor drug that has been used to treat a variety of cancers including breast cancer and prostate cancer (1, 2) . A major long term toxic effect of this drug is the development of cardiac damage (e.g. cardiomyopathy and heart failure) in cancer patients treated with DOX (3, 4) . Endothelial dysfunction is an acute toxic side effect of DOX. One of the proposed mechanisms responsible for the acute and chronic toxicity is the formation of ROS formed from the redox activation of DOX (5) (6) (7) (8) . DOX, a quinone-containing drug, undergoes a one-electron reduction to a semiquinone intermediate that generates superoxide anion and hydrogen peroxide (9, 10) . Several flavoprotein reductases, including endothelial nitric-oxide synthase, are capable of initiating the redox activation of DOX (11) (12) (13) .
The possible involvement of iron in DOX-induced cardiotoxicity became evident from studies in which iron chelators (ICRF-187 or dexaroxane) were shown to be cardioprotective (14, 15) . It was postulated that iron needed to catalyze intracellular radical reactions originated from mitochondrial aconitase or ferritin, the intracellular iron storage protein (16 -18) . Both superoxide and DOX semiquinone were shown to release iron from aconitase or ferritin (16, 17) . Recently, it was reported that apoptosis in endothelial cells and myocytes was induced by submicromolar concentrations of DOX (19, 20) . Treatment with intracellular iron chelator inhibited DOX-induced apoptosis in neonatal myocytes (19) . Thus, the intracellular iron was thought to play a major role in initiating DOXinduced apoptosis (19) .
Previously it has been shown that cellular iron is regulated by the cell surface transferrin receptor (TfR)-mediated uptake of iron as transferrin iron (21, 22) . Recent reports indicate that the cellular oxidative damage caused by ROS is critically controlled by cellular iron homeostasis (23) (24) (25) . Exposure of murine fibroblasts to hydrogen peroxide decreased ferritin synthesis and enhanced the expression of TfR mRNA (24) , implicating a possible link between oxidant generation and TfR-mediated iron regulation.
In this study, we tested the hypothesis that the TfR-dependent uptake of iron is responsible for DOX-induced apoptosis in endothelial cells. The results from this study show that an anti-TfR monoclonal antibody (42/6) dramatically blocked DOX-induced apoptosis in endothelial cells, suggesting that the TfR-dependent influx of extracellular iron is responsible for mediating DOX-induced apoptosis. DOX-induced iron uptake was inhibited by the pretreatment of cells with cell-permeable antioxidants and iron chelators. The biological implications of oxidant-induced iron signaling in endothelial cells are discussed.
EXPERIMENTAL PROCEDURES
Materials-␣-Phenyl-tert-butyl nitrone (PBN), 2-phenyl-1,2-benzisoselenazol-3(2H)-one (ebselen), doxorubicin (DOX), and desferral (or also deferoxamine) were obtained from Sigma. HBED and dexrazoxane (ICRF-187) were gifts from Dr. Cherakuri Muralikrishna (National * This work was supported by National Institutes of Health Grants RR01008 and CA77822. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ 2 ) in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (FBS), L-glutamine (4 mmol/liter), penicillin (100 units/ml), and streptomycin (100 g/ml), and incubated at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. On the day of the treatment, the medium was replaced with Dulbecco's modified Eagle's medium containing 2% FBS, which contains ϳ25-30 g transferrin/ml. The above condition was applied to all of the experiments performed in this study. The cells were passaged as described by Balla et al. (27) and used between passages 4 and 12.
Measurement of 55 Fe Uptake in Endothelial Cells-Bovine aortic endothelial cells were grown in Dulbecco's modified Eagle's medium containing 10% FBS until confluence. On the day of the treatment, the medium was replaced with Dulbecco's modified Eagle's medium containing 2% FBS, and the cells were allowed to adjust to the medium conditions. 0.1 Ci of 55 Fe (ferric chloride) was added to the medium for 0 -16 h. An aliquot of medium was taken to measure the label in the medium. The cells were washed twice with Dulbecco's phosphate-buffered saline (DPBS) and lysed with PBS (containing 0.1% Triton), an aliquot was taken for the protein estimation (Lowry method), and the remaining lysate was used for counting in a ␤ counter (28) .
Measurement of Apoptosis by TUNEL Assay-The terminal deoxynucleotidyltransferase-mediated nick end labeling (TUNEL) assay was used for microscopic detection of apoptosis (19, 20) . This assay is based on labeling of 3Ј-free hydroxyl ends of the fragmented DNA with fluorescein-dUTP catalyzed by terminal deoxynucleotidyl transferase. Procedures were followed according to the commercially available kit (ApoAlert) from CLONTECH. Apoptotic cells exhibit a strong nuclear green fluorescence that can be detected using a standard fluorescein filter (520 nm). All cells stained with propidium iodide exhibited a strong red cytoplasmic fluorescence at 620 nm. The areas of apoptotic cells were detected by fluorescence microscopy equipped with rhodamine and fluorescein isothiocyanate filters. The quantification of apoptosis was performed using a Metamorph image analysis package.
Measurement of Caspase-3 Activity-Caspase-3-like activity is increased through a protease cascade during apoptosis in the early stage (29 -31) . Following treatment with DOX and other antioxidants, the cells were washed with ice-cold PBS and lysed with cell lysis buffer (caspase-3 assay kit; CLONTECH). The samples were incubated on ice for 10 min and then centrifuged in a microcentrifuge at 12,000 ϫ g for 3 min at 4°C to remove the cellular debris. The caspase-3 activity in the supernatant was measured in a spectrophotometer using acetyl-AspGlu-Val-Asp-p-nitroanilide as a substrate according to the manufacturer's instructions provided with the assay kit (20) .
Determination of TfR Levels-BAEC were washed with ice-cold PBS and resuspended in 100 l of RIPA buffer (20 mM Tris-HCl, pH 7.4, 2.5 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 1% SDS, 100 mM NaCl, 100 mM sodium fluoride). To a 10-ml solution of the above, the following agents were added: 1 mM sodium vanadate, 10 g/ml aprotinin, 10 g/ml leupeptin, and 10 g/ml pepstatin inhibitors. The cells were homogenized by passing the suspension through a 25-gauge needle (10 strokes). The lysate was centrifuged at 750 ϫ g for 10 min at 4°C to pellet out the nuclei. The remaining supernatant was centrifuged for 30 min at 12,000 ϫ g. Protein was determined by the Lowry method, and 20 g was used for the Western blot analysis. The proteins were resolved on 8% SDS-polyacrylamide gels and blotted onto nitrocellulose membranes. Membranes were washed with Tris-buffered saline (140 mM NaCl, 50 mM Tris-HCl, pH 7.2) containing 0.1% Tween 20 and 5% skim milk to block the nonspecific protein binding. Membranes were incubated with mouse anti-human transferrin receptor monoclonal antibody (Zymed Laboratories Inc., San Francisco, CA; 1 g/ml in Trisbuffered saline containing 0.1% Tween 20 for 2 h at room temperature), washed five times, and then incubated with horseradish peroxidaseconjugated rabbit anti-mouse IgG (1:5000) for 1.5 h at room temperature. The TfR band was detected using the ECL method (Amersham Biosciences) (32, 33) .
Measurement of Aconitase Activity-BAEC were washed twice with cold PBS and lysed with buffer containing 0.2% Triton X-100, 100 M diethylenetriamine pentaacetic acid, and 5 mM citrate in PBS. The activity of aconitase was measured in 100 mM Tris-HCl (pH 8.0) containing 20 mM D,L-trisodium isocitrate. An extinction coefficient for cis-aconitate of 3.6 mM at 240 nm was used (34) .
Electrophoretic Mobility Shift Assay-IRP/IRE binding was measured by electrophoretic mobility shift assay. 32 P-Labeled IRE mRNA for the RNA band shift assay was prepared using as a template a 1000-base pair rat L ferritin pseudogene that contains the conserved IRE sequence. The plasmid (p66-L gene) containing this insert (which was generously provided by Dr. Elizabeth Leibold) (35) was linearized with SmaI (Invitrogen) and used for in vitro transcription of IRE mRNA. Transcription was carried out with Sp6 RNA polymerase using a Riboprobe transcription system from Promega.
Measurement of Oxidative Stress-The determination of intracellular oxidant production was based on the oxidation of DCFH to a fluorescent 2Ј,7Ј-dichlorofluorescein (DCF) (36, 37) . Following pretreatment of BAEC with DOX and antiapoptotic antioxidants, the medium was aspirated, and cells were washed twice with DPBS and incubated in 1 ml of medium without FBS. DCFH diacetate was added at a final concentration of 10 M and incubated for 20 min. The cells were then washed once with DPBS and maintained in 1 ml of culture medium. Fluorescence was monitored using a Nikon fluorescence microscope equipped with an fluorescein isothiocyanate filter. The intensity values were calculated using the Metamorph software.
Hydroethidine (Dihydroethidium) Staining-The redox-sensitive fluorophore hydroethidine (dihydroethidium) has been used to monitor intracellular oxidative stress (38) . Following pretreatment of BAEC with antiapoptotic antioxidants and DOX, culture medium was aspirated, and the cells were washed once with DPBS and incubated in fresh culture medium without FBS. Hydroethidine (10 mol/liter) was added to the cells, and the incubation was continued for 20 min, during which hydroethidine was oxidized to fluorophore ethidium. Fluorescence images were obtained using a Nikon fluorescence microscope equipped with a rhodamine filter. The fluorescence intensity values from three different fields of view were calculated using the Metamorph software, and the average values are represented. 
RESULTS
Transferrin Receptor-mediated 55 Fe Uptake by Endothelial Cells-Incubation of BAEC with 0.5 M DOX caused an increase in the cellular uptake of 55 Fe (Fig. 1A) . As shown in Fig.  1 , DOX treatment induced a decrease in 55 Fe content in the medium and an increase in 55 Fe uptake by cells. Fig. 1B shows the time-dependent increase in 55 Fe uptake by cells following DOX treatment. DOX-induced iron uptake reached a maximum within a period of 2-3 h. To examine the involvement of the transferrin receptor, we monitored the effect of DOX on the expression of cellular TfR levels by Western blotting analysis. Fig. 2 (A and B) shows that DOX treatment produced an increase in TfR levels within 2 h, suggesting that cellular uptake of iron likely occurs via the TfR-dependent mechanism. The involvement of TfR in DOX-induced iron transport was further confirmed using the monoclonal (IgA) anti-TfR antibody (42/6) that specifically binds to the extracellular domain of the TfR and blocks receptor endocytosis (32) . This antibody recognizes both human and bovine TfR (32) . In the presence of 42/6, iron cannot enter the cell through TfR. Thus, a distinction between TfR-dependent and TfR-independent iron uptake can be made using this antibody. Fig. 2C shows that the presence of 12 g/ml 42/6 dramatically inhibited DOX-induced 55 Fe uptake. These results strongly suggest that DOX-induced iron uptake occurs through a TfR-dependent transport mechanism. In control experiments, when BAEC were incubated with 12 g/ml IgG class immunoglobulin that does not bind to the extracellular domain of the TfR, DOX-induced 55 Fe uptake was not inhibited (not shown).
Effect of Antioxidants on DOX-induced 55 Fe Uptake and TfR Expression-We examined the effects of small molecular weight, cell-permeable superoxide dismutase mimetics (MnT-BAP and FeTBAP) (39, 40) , the lipophilic glutathione peroxidase mimetic (ebselen) (41) , and an open chain nitrone-free radical trap (PBN) (42) on DOX-induced 55 Fe uptake and TfR levels. BAEC were treated with each compound for 2 h prior to the addition of 0.5 M DOX. In the presence of FeTBAP (20 M), ebselen (50 M), and PBN (100 M), DOX-induced iron uptake was inhibited (Fig. 3A) . Concomitantly, TfR levels were measured. Fig. 3B shows that antioxidants that inhibit DOX-induced 55 Fe uptake caused a marked decrease in the expression of TfR. For example, treatment of BAEC with either FeTBAP, PBN, or ebselen (data not shown) along with DOX inhibited TfR expression by 75 and 60%, respectively, as measured by densitometry scanning (Fig. 3C) . These findings suggest that antioxidants inhibit DOX-mediated 55 Fe uptake through the down-regulation of TfR.
Effect of Anti-TfR Antibody, Antioxidants, and Iron Chelators on DOX-induced Apoptosis-Treatment of BAEC with 0.5 M DOX enhanced the fraction of TUNEL-positive BAEC from 2 to 65% (Fig. 4, A and B) . Cells treated with anti-TfR monoclonal antibody 42/6 (12 g/ml) dramatically decreased the fraction of TUNEL-positive nuclei (Fig. 4C) . Pretreatment with nitrone spin trap, PBN, significantly decreased the TUNELpositive staining in DOX-treated BAEC (Fig. 4H) . Pretreatment of cells with the cell-permeable iron chelator, dexrazoxane, or ICRF-187 for 2 h inhibited apoptosis induced by DOX (Fig. 4F) . The addition of ICRF-187 to cells, without pretreatment, did not inhibit DOX-induced apoptosis (Fig. 4G) . These results indicate that DOX-mediated apoptosis is accompanied by TfR-dependent cellular iron uptake and that pretreatment with antioxidants or iron chelators inhibits DOX-induced apoptosis. 
Effect of Anti-TfR Antibody and Cell-permeable Iron Chelators on DOX-induced Caspase-3 Activation-Previously
we reported that exposure of BAEC or cardiomyocytes to submicromolar levels of DOX induced caspase-3 activation (20) . Caspase-3 activity was presumably increased through a protease cascade during the early stages of apoptosis (29 -31) . As shown in Fig. 5A (closed circles) , when BAEC were incubated with 0.5 M DOX, caspase-3 proteolytic activity increased by 3-fold after 4 h and remained at that level for almost 16 h. In the presence of anti-TfR antibody, DOX-induced caspase-3 activation was considerably inhibited (ϳ50%) up to 8 h (Fig. 5A,  closed triangles) . Note that there is no total one-to-one correspondence between DNA fragmentation and caspase-3 activation during the early stages (cf. Figs. 4 and 5) , because caspase-3 activation precedes DNA fragmentation. However, prolonged incubation (ϳ16 h) of BAEC with anti-TfR antibody caused an increase in caspase activation in control cells, because antibodies themselves cause iron deprivation. This finding implicates a critical role of TfR-dependent iron uptake during DOX-induced apoptotic signaling.
Next, we examined the effect of cell-permeable iron chelators on caspase-3 activation induced by DOX. Fig. 5B shows that preincubation of cells with iron chelators is absolutely essential to inhibit DOX-induced caspase-3 activation. Preincubation of cells with ICRF-187, deferoxamine, or HBED for 2 h prior to the addition of DOX caused a 70% decrease in caspase-3 activity (Fig. 5B) . Previously we reported that ICRF-187 did not affect DOX apoptosis in BAEC and cardiomyocytes (20) . In that study (20) , cells were not preincubated with the iron chelator. Preincubation of cells with antioxidants also inhibited DOXinduced caspase-3 activation (Fig. 5B) . The results from the present study strongly suggest that preincubation with cellpermeable chelators of iron is extremely critical to ameliorating DOX-induced apoptosis.
Effect of Antioxidants and Anti-TfR Antibody on DOX-induced Inactivation of Aconitase and IRP-1 Activity-Inactivation of aconitase has been used as a physiologically relevant indicator of the intracellular oxidant formation (43) (44) (45) . As shown in Fig. 6A , DOX (0.5 M) treatment inhibited aconitase activity (40%) within 2-3 h. Pretreatment with antioxidants (FeTBAP, PBN, and ebselen) almost fully restored aconitase activity (Fig. 6B) . Fig. 6C shows that anti-TfR antibody and pretreatment with cell-permeable iron chelators restored the activity of aconitase, indicating that TfR-mediated cellular iron transport exacerbates DOX-induced aconitase inactivation. Earlier studies (24, 25) have shown that IRP-1, a central cytoplasmic regulator of cellular iron metabolism, is oxidatively activated to bind to mRNA IRE. Treatment of cells with 0.5 M DOX for 0 -8 h caused a dose-dependent increase in IRP-1 activity. This activity was significantly increased within 2 h of DOX treatment (Fig. 6D, right panel) with respect to total IRP-1 (active and inactive). To determine whether the increase in IRP-1 activity with DOX treatment was due to an increase in total IRP-1, lysates were treated with 1% 2-mercaptoethenol, which activates IRP-1 to the high affinity RNA-binding form (46) . Under these conditions, major differences in IRP binding to IRE were not observed between control and DOX-treated cells (Fig. 6D, left panel) . This suggests that DOX treatment clearly induces activation of IRP-1. The present findings are in agreement with a recent study reporting that DOX at low concentrations (Ϸ1 M) activates IRP-1 in cardiomyocytes (47) . However, at higher concentrations (Ͼ5 M), DOX irreversibly inactivates IRP-1 (47) .
Effect of Anti-TfR Antibody and Iron Chelators on DOXinduced Reactive
Oxygen Species-The oxidation of DCFH, a nonfluorescent probe, to a fluorescent DCF (36, 37) has been used to measure intracellular H 2 O 2 by numerous investigators (25, 36, 37, 48) . Although H 2 O 2 itself does not react with DCFH to form DCF, it was proposed that intracellular peroxidases or redox-active metal ions could catalyze the oxidation of DCFH to DCF in the presence of H 2 O 2 (49, 50) . The present data show that DOX produced a dose-dependent increase in DCF staining (Fig. 7) . Pretreatment of cells with anti-TfR antibody greatly inhibited DOX-induced DCF staining (Fig. 7A) , suggesting that oxidation of DCFH to DCF was mediated by TfR-dependent iron uptake and H 2 O 2 . Additional support for the intermediacy of iron in DCF staining also came from experiments using different iron chelators. Pretreatment of BAEC with iron chelators (deferoxamine, HBED, and ICRF-187) for 2 h greatly inhibited DOX-induced DCF staining (Fig. 7A) . Thus, DOXinduced oxidation of DCFH to DCF in BAEC is clearly mediated by both H 2 O 2 and intracellular iron derived from TfR-dependent transport mechanism. The DCFH assay based on the oxidation of DCFH to DCF to assess intracellular H 2 O 2 requires the availability of cellular co-oxidants (peroxidase, cytochrome, or redox-active iron) (49 -51) . The present findings strongly suggest a role of cellular iron in DCF fluorescence.
Next, we determined the effect of anti-TfR antibody on DOXinduced ethidium staining (Fig. 7B) , which reportedly detects intracellular superoxide generation (38, 52) . As shown in 7B, there was a dose-dependent increase in the intensity of red fluorescence with DOX, indicative of enhanced superoxide generation. However, anti-TfR antibody did not have any effect on DOX-induced ethidium fluorescence (Fig. 7B) . This suggests that DOX-induced superoxide generation in BAEC is not affected by 55 Fe transport. This result also reveals that anti-TfR antibody does not interfere with the cellular uptake and reductive activation of DOX (Fig. 7B) . In addition, iron chelators had no effect on the intensity of red fluorescence, indicating that superoxide production remained unchanged (Fig. 7B) . DISCUSSION Our results demonstrate that DOX-mediated apoptosis in endothelial cells is accompanied by a significant increase in TfR-mediated uptake of transferrin iron and that blockade of iron uptake by an anti-transferrin receptor antibody abolishes DOX-induced apoptosis. In addition, TfR-mediated iron uptake and apoptotic signaling are mitigated by antioxidants that inhibit DOX-dependent intracellular oxidant generation. These findings place the TfR as a "gatekeeper" for iron uptake by BAEC and act as an effective modulator of apoptotic signaling initiated by DOX.
Role of Iron in DOX-induced Toxicity and Apoptosis: Old and New Perspectives-The possible involvement of iron in DOXinduced cardiotoxicity was demonstrated in the early 1970s when a series of nonpolar derivatives of EDTA, including a bis-ketopiperazine derivative (ICRF-187 or dexrazoxane), was reported to prevent DOX-mediated cardiac damage and myocardial dysfunction in an isolated perfused heart model and in whole animals (53) . It has been proposed that DOX semiquinone and superoxide anion derived from redox activation of DOX could mobilize iron from ferritin or aconitase (16 -18) . More recently, it was reported that the secondary alcohol metabolite of DOX could cause the release of iron from cytosolic fractions of myocardial tissues (54) . DOX itself can form iron complexes (iron binding constant, ϳ10
18 ) under acidic conditions, and this preformed complex has been shown to oxidize lipids, protein, and DNA (55, 56) . The current thinking is that DOX modifies the cellular iron-induced redox signaling through oxidative modification of aconitase (17, (23) (24) (25) . Published reports on redox signaling of iron support this view (21) (22) (23) (24) (25) . Exposure of hydroperoxides to murine B6 fibroblasts increased the expression of the TfR mRNA, because of the induction of a 98-kDa, cytosolic iron regulatory protein (IRP-1) (24, 25) . This process also leads to the reduced synthesis of ferritin, an intracellular iron storage protein, which triggers a signal for increased iron uptake. Quinone-induced oxidative stress has also been reported to induce iron signaling via IRP-1 (25) . Treatment of murine B6 fibroblasts with a redox-active quinone such as menadione (2-methyl-1,4-naphthoquinone or vitamin K 3 ) activated IRP-1 binding to IREs through increased generation of intracellular oxidants (25) . However, the IRP-1 response in cells treated with extracellular and intracellular H 2 O 2 has been reported to be different (25) .
In the present study we have shown that DOX causes an induction in TfR expression and increases iron influx into cells through TfR. Antioxidants inhibit DOX-induced TfR overexpression and the associated iron uptake, implicating a role for oxidant-induced iron signaling mechanism in DOX toxicity. DOX-induced oxidative stress and iron signaling is shown in Scheme 1. As shown in Scheme 1, the TfR plays a key role in regulating the entry of iron into cells. The cellular iron-sensing mechanism enables synchronized regulation of TfR and ferritin levels in cells. TfR and ferritin syntheses are regulated by iron at the mRNA translation level by the interaction of cytoplasmic regulatory proteins (IRPs) with their respective mRNAs (57) (58) (59) . The IRPs (IRP-1 and-2) function as sensors of cellular iron status. Under conditions of iron deprivation or when the [4Fe-4S] cluster in aconitase is disassembled, the IRPs bind with high affinity to IRE present on TfR and ferritin mRNAs. The increased binding to TfR mRNA stabilizes the mRNA, resulting in increased mRNA translation and increased receptor synthesis (Scheme 1). On the other hand, when cellular iron is in excess, IRP-1/IRE binding is decreased, leading to rapid degradation of TfR mRNA and to efficient translation of ferritin mRNA. IRP-1 senses iron levels by switching between cytoplasmic aconitase and IRP-1, an IRE-binding protein (Scheme 1). Because a large portion of the iron needs of the cell is for the assembly of iron sulfur clusters and heme biosynthesis in the mitochondria, the partial inactivation of the mitochondrial iron sulfur protein (e.g. aconitase) is presumably sufficient to stimulate cellular iron signaling (60) . Although the exact mechanism of oxidant-induced activation of IRP-1 remains unknown, it has been proposed that either a direct interaction between the 4Fe-4S cluster of IRP-1 and H 2 O 2 (or derived oxidant) or an H 2 O 2 -dependent stress-response signaling pathway is operative (23). Scheme 1 shows the relationship between DOX-in- duced mitochondrial and cytosolic ROS generation, glutathione depletion, iron-sulfur protein (e.g. aconitase) inactivation, IRP-1 activation, TfR-mediated iron transport, and apoptotic cell death.
Effect of DOX on the Molecular Regulation of Transferrin Receptor Expression by
Recent reports indicate that DOX is primarily sequestered in mitochondria in DOX-treated cells (61) . The intramitochondrial concentration of DOX was nearly 100 times higher (50 -100 M) in cells treated with 0.5-1.0 M of extracellular DOX. The enzyme involved in the activation of DOX in mitochondria appears to be the NADH dehydrogenase (10) . The one-electron reduction of DOX to its semiquinone radical by NADH dehydrogenase, followed by its redox cycling in the presence of molecular oxygen generates O 2 . , which dismutates to form H 2 O 2 in the mitochondria (10 (20) . These results differed from those previously reported for myocytes, where ICRF-187 significantly inhibited DOX-induced apoptosis (19) . In the present study, we show that preincubation of BAEC with three different iron chelators (desferral (or deferoxamine), HBED, and ICRF-187) is absolutely essential for inhibiting DOX-induced apoptosis (Fig. 5B) . The three iron chelators are presumably transported into cells by different mechanisms. Deferoxamine is hydrophilic and easily endocytosed into cells, whereas the lipophilic HBED readily diffuses into cells and chelates intracellular iron (63) . ICRF-187 is metabolized intracellularly to generate an in situ iron chelator (64) . Because treatment with ebselen completely inhibits DOX-induced apoptosis in endothelial cells and myocytes, it appears that both H 2 O 2 and iron are responsible for DOX apoptosis (19, 20) .
Oxidative Stress, Iron Signaling, and Endothelial Apoptosis-The role of oxidant-induced iron signaling may have broader applications in oxidative vascular biology. Endothelial cell injury is presumed to be an early oxidative insult in the development of atherosclerosis (65). It was proposed that H 2 O 2 generated in leukocytes and macrophages caused endothelial dysfunction (66) . H 2 O 2 and other peroxides including a lipid hydroperoxide were shown to induce NAD(P)H oxidasedependent O 2 . production in nonphagocytic cells (67) . Recently, it was reported that hyperglycemia could promote transition metal-catalyzed hydroxyl radical reactions in the microenvironment of the diabetic artery wall (68, 69) . Another clinical study found that redox-active iron might contribute to endothelial dysfunction in atherosclerotic patients and demonstrated the beneficial effects of iron chelation with desferral (70) . From these reports, it is evident that the role of cellular iron signaling and iron-mediated oxidative damage is relevant in cardiovascular and lung diseases (68, 71, 72 ) that should perhaps be more fully explored from a new perspective (i.e. oxidant-induced iron signaling mechanism). SCHEME 1. A proposed model for oxidant-induced cellular uptake of iron. DOX-induced ROS inactivates the aconitase enzyme, which in turn increases the levels of non-iron-bound IRP-1, enabling it to find to the 3Ј-untranslated region of TfR mRNA, thereby enhancing its stability and level of expression. Elevation of TfR expression enhances cellular uptake of iron, exacerbates oxidative stress, and triggers apoptosis. Antioxidants and iron chelators lower DOX-induced intracellular ROS and prevent the accumulation of iron-free IRP-1, thereby blocking the induction of TfR expression and iron uptake.
